BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8700542)

  • 1. Telomerase activity in human renal cell carcinoma.
    Mehle C; Piatyszek MA; Ljungberg B; Shay JW; Roos G
    Oncogene; 1996 Jul; 13(1):161-6. PubMed ID: 8700542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere shortening in renal cell carcinoma.
    Mehle C; Ljungberg B; Roos G
    Cancer Res; 1994 Jan; 54(1):236-41. PubMed ID: 8261445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length dynamics in telomerase-positive immortal human cell populations.
    Bryan TM; Englezou A; Dunham MA; Reddel RR
    Exp Cell Res; 1998 Mar; 239(2):370-8. PubMed ID: 9521855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of telomerase activity and telomere function in cancer.
    Gordon KE; Parkinson EK
    Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic changes and telomerase activity in human renal cell carcinoma.
    Rohde V; Sattler HP; Oehlenschläger B; Forster S; Zwergel T; Seitz G; Wullich B
    Clin Cancer Res; 1998 Jan; 4(1):197-202. PubMed ID: 9516971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity and alterations in telomere length in human brain tumors.
    Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
    Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hTERT expression in sporadic renal cell carcinomas.
    Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
    J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process.
    Ducray C; Pommier JP; Martins L; Boussin FD; Sabatier L
    Oncogene; 1999 Jul; 18(29):4211-23. PubMed ID: 10435634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple pathways to cellular senescence: role of telomerase repressors.
    Oshimura M; Barrett JC
    Eur J Cancer; 1997 Apr; 33(5):710-5. PubMed ID: 9282109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase.
    LaBranche H; Dupuis S; Ben-David Y; Bani MR; Wellinger RJ; Chabot B
    Nat Genet; 1998 Jun; 19(2):199-202. PubMed ID: 9620782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity in ovarian tumors.
    Murakami J; Nagai N; Ohama K; Tahara H; Ide T
    Cancer; 1997 Sep; 80(6):1085-92. PubMed ID: 9305709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of telomere length by the human telomeric protein TRF1.
    van Steensel B; de Lange T
    Nature; 1997 Feb; 385(6618):740-3. PubMed ID: 9034193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere reduction and telomerase inactivation during neuronal cell differentiation.
    Kruk PA; Balajee AS; Rao KS; Bohr VA
    Biochem Biophys Res Commun; 1996 Jul; 224(2):487-92. PubMed ID: 8702416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple pathways for the regulation of telomerase activity.
    Holt SE; Wright WE; Shay JW
    Eur J Cancer; 1997 Apr; 33(5):761-6. PubMed ID: 9282114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.
    McChesney PA; Aisner DL; Frank BC; Wright WE; Shay JW
    Mol Cell Biol Res Commun; 2000 May; 3(5):312-8. PubMed ID: 10964756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy.
    Healy KC
    Oncol Res; 1995; 7(3-4):121-30. PubMed ID: 8555645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.